Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, Davis
Peking University First Hospital
Jinling Hospital, China
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
University of California, San Francisco
Royal Marsden NHS Foundation Trust
Thomas Jefferson University
City of Hope Medical Center
Alliance for Clinical Trials in Oncology
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Northwestern University
Fox Chase Cancer Center
OHSU Knight Cancer Institute